{"entity":{"type":"insider","cik":"0002021238","url":"/insider/0002021238","json_url":"/insider/0002021238.json","name":"Kreitzer Anatol","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":3,"first":"2026-04-17","last":"2026-07-20","span_basis":"filed_date"},"name_variants":[{"name":"Kreitzer Anatol","source":"filing","n_filings":3,"first_seen":"2026-04-17","last_seen":"2026-07-20"}],"transactions":[{"id":6232993,"accession":"0002021238-26-000010","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0002021238-26-000010","line_url":"/filing/0002021238-26-000010","is_derivative":false,"issuer_cik":"0001770069","issuer_name":"MapLight Therapeutics, Inc.","issuer_ticker":"MPLT","issuer_name_source":null,"issuer_url":"/issuer/0001770069","owner_cik":"0002021238","owner_name":"Kreitzer Anatol","owner_display_name":"Kreitzer Anatol","owner_url":"/insider/0002021238","role":"Officer (Chief Discovery Officer)","role_mark":"O","role_mark_label":"Officer (Chief Discovery Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Discovery Officer","security_title":"Voting Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17173.0,"shares_display":"17,173","price_per_share":37.60080649857334,"price_display":"37.60","price_state":"stated","total_value":645718.65,"total_display":"645,718.65","total_whole":"645,719","shares_owned_after":175106.0,"shares_owned_after_display":"175,106","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-17","filed_date":"2026-07-20","scope":"insider","n_lines":3},{"id":6232975,"accession":"0002021238-26-000010","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0002021238-26-000010","line_url":"/filing/0002021238-26-000010","is_derivative":false,"issuer_cik":"0001770069","issuer_name":"MapLight Therapeutics, Inc.","issuer_ticker":"MPLT","issuer_name_source":null,"issuer_url":"/issuer/0001770069","owner_cik":"0002021238","owner_name":"Kreitzer Anatol","owner_display_name":"Kreitzer Anatol","owner_url":"/insider/0002021238","role":"Officer (Chief Discovery Officer)","role_mark":"O","role_mark_label":"Officer (Chief Discovery Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Discovery Officer","security_title":"Voting Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9056.0,"shares_display":"9,056","price_per_share":36.79712014134276,"price_display":"36.80","price_state":"stated","total_value":333234.72,"total_display":"333,234.72","total_whole":"333,235","shares_owned_after":193671.0,"shares_owned_after_display":"193,671","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-16","filed_date":"2026-07-20","scope":"insider","n_lines":2},{"id":6232968,"accession":"0002021238-26-000010","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0002021238-26-000010","line_url":"/filing/0002021238-26-000010","is_derivative":false,"issuer_cik":"0001770069","issuer_name":"MapLight Therapeutics, Inc.","issuer_ticker":"MPLT","issuer_name_source":null,"issuer_url":"/issuer/0001770069","owner_cik":"0002021238","owner_name":"Kreitzer Anatol","owner_display_name":"Kreitzer Anatol","owner_url":"/insider/0002021238","role":"Officer (Chief Discovery Officer)","role_mark":"O","role_mark_label":"Officer (Chief Discovery Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Discovery Officer","security_title":"Voting Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10055.0,"shares_display":"10,055","price_per_share":36.493311785181504,"price_display":"36.49","price_state":"stated","total_value":366940.25,"total_display":"366,940.25","total_whole":"366,940","shares_owned_after":205645.0,"shares_owned_after_display":"205,645","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-15","filed_date":"2026-07-20","scope":"insider","n_lines":2},{"id":5780154,"accession":"0002021238-26-000008","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0002021238-26-000008","line_url":"/filing/0002021238-26-000008","is_derivative":false,"issuer_cik":"0001770069","issuer_name":"MapLight Therapeutics, Inc.","issuer_ticker":"MPLT","issuer_name_source":null,"issuer_url":"/issuer/0001770069","owner_cik":"0002021238","owner_name":"Kreitzer Anatol","owner_display_name":"Kreitzer Anatol","owner_url":"/insider/0002021238","role":"Officer (Chief Discovery Officer)","role_mark":"O","role_mark_label":"Officer (Chief Discovery Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Discovery Officer","security_title":"Voting Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45422.0,"shares_display":"45,422","price_per_share":29.656693012196733,"price_display":"29.66","price_state":"stated","total_value":1347066.31,"total_display":"1,347,066.31","total_whole":"1,347,066","shares_owned_after":219011.0,"shares_owned_after_display":"219,011","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-27","filed_date":"2026-04-29","scope":"insider","n_lines":3},{"id":6143548,"accession":"0002021238-26-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0002021238-26-000006","line_url":"/filing/0002021238-26-000006#line-1","is_derivative":false,"issuer_cik":"0001770069","issuer_name":"MapLight Therapeutics, Inc.","issuer_ticker":"MPLT","issuer_name_source":null,"issuer_url":"/issuer/0001770069","owner_cik":"0002021238","owner_name":"Kreitzer Anatol","owner_display_name":"Kreitzer Anatol","owner_url":"/insider/0002021238","role":"Officer (Chief Discovery Officer)","role_mark":"O","role_mark_label":"Officer (Chief Discovery Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Discovery Officer","security_title":"Voting Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3316.0,"shares_display":"3,316","price_per_share":26.61,"price_display":"26.61","price_state":"stated","total_value":88238.76,"total_display":"88,238.76","total_whole":"88,239","shares_owned_after":256612.0,"shares_owned_after_display":"256,612","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-15","filed_date":"2026-04-17","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":11,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001770069","name":"MapLight Therapeutics, Inc.","url":"/issuer/0001770069","role":"Officer (Chief Discovery Officer)","n_filings":3,"first_seen":"2026-04-17","last_seen":"2026-07-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0002021238","retrieved_at":"2026-08-26T05:27:53+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}